Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Research Report 2025

Publication ID:

PB502255463

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Vagus Nerve Stimulation Implantable Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Vagus Nerve Stimulation (VNS) implantable device is a medical device used to treat certain neurological and psychiatric conditions by stimulating the vagus nerve. The vagus nerve is a key component of the autonomic nervous system and plays a vital role in regulating various bodily functions.
North American market for Vagus Nerve Stimulation Implantable Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Vagus Nerve Stimulation Implantable Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Vagus Nerve Stimulation Implantable Device include LivaNova, ReShape Lifesciences, Boston Scientific, Cyberonics, SenTiva, Inspire Medical, NeuroPace, Stimwave, Cerbomed GmbH, ImThera Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vagus Nerve Stimulation Implantable Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vagus Nerve Stimulation Implantable Device.
The Vagus Nerve Stimulation Implantable Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vagus Nerve Stimulation Implantable Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vagus Nerve Stimulation Implantable Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
LivaNova
ReShape Lifesciences
Boston Scientific
Cyberonics
SenTiva
Inspire Medical
NeuroPace
Stimwave
Cerbomed GmbH
ImThera Medical
EnteroMedics
Segment by Type
Metallic
Ceramics
Polymeric
Segment by Application
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vagus Nerve Stimulation Implantable Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vagus Nerve Stimulation Implantable Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Vagus Nerve Stimulation Implantable Device 麻豆原创 Overview
1.1 Product Definition
1.2 Vagus Nerve Stimulation Implantable Device by Type
1.2.1 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Metallic
1.2.3 Ceramics
1.2.4 Polymeric
1.3 Vagus Nerve Stimulation Implantable Device by Application
1.3.1 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Neurology Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Research Centers
1.4 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Vagus Nerve Stimulation Implantable Device Revenue 2020-2031
1.4.2 Global Vagus Nerve Stimulation Implantable Device Sales 2020-2031
1.4.3 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vagus Nerve Stimulation Implantable Device 麻豆原创 Competition by Manufacturers
2.1 Global Vagus Nerve Stimulation Implantable Device Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Vagus Nerve Stimulation Implantable Device Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Vagus Nerve Stimulation Implantable Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vagus Nerve Stimulation Implantable Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vagus Nerve Stimulation Implantable Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vagus Nerve Stimulation Implantable Device, Product Type & Application
2.7 Global Key Manufacturers of Vagus Nerve Stimulation Implantable Device, Date of Enter into This Industry
2.8 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Competitive Situation and Trends
2.8.1 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Vagus Nerve Stimulation Implantable Device Players 麻豆原创 Share by Revenue
2.8.3 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Scenario by Region
3.1 Global Vagus Nerve Stimulation Implantable Device 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vagus Nerve Stimulation Implantable Device Sales by Region: 2020-2031
3.2.1 Global Vagus Nerve Stimulation Implantable Device Sales by Region: 2020-2025
3.2.2 Global Vagus Nerve Stimulation Implantable Device Sales by Region: 2026-2031
3.3 Global Vagus Nerve Stimulation Implantable Device Revenue by Region: 2020-2031
3.3.1 Global Vagus Nerve Stimulation Implantable Device Revenue by Region: 2020-2025
3.3.2 Global Vagus Nerve Stimulation Implantable Device Revenue by Region: 2026-2031
3.4 North America Vagus Nerve Stimulation Implantable Device 麻豆原创 Facts & Figures by Country
3.4.1 North America Vagus Nerve Stimulation Implantable Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vagus Nerve Stimulation Implantable Device Sales by Country (2020-2031)
3.4.3 North America Vagus Nerve Stimulation Implantable Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vagus Nerve Stimulation Implantable Device 麻豆原创 Facts & Figures by Country
3.5.1 Europe Vagus Nerve Stimulation Implantable Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vagus Nerve Stimulation Implantable Device Sales by Country (2020-2031)
3.5.3 Europe Vagus Nerve Stimulation Implantable Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vagus Nerve Stimulation Implantable Device 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Vagus Nerve Stimulation Implantable Device 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vagus Nerve Stimulation Implantable Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Vagus Nerve Stimulation Implantable Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vagus Nerve Stimulation Implantable Device 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Vagus Nerve Stimulation Implantable Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vagus Nerve Stimulation Implantable Device Sales by Country (2020-2031)
3.7.3 Latin America Vagus Nerve Stimulation Implantable Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vagus Nerve Stimulation Implantable Device 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Vagus Nerve Stimulation Implantable Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vagus Nerve Stimulation Implantable Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vagus Nerve Stimulation Implantable Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vagus Nerve Stimulation Implantable Device Sales by Type (2020-2031)
4.1.1 Global Vagus Nerve Stimulation Implantable Device Sales by Type (2020-2025)
4.1.2 Global Vagus Nerve Stimulation Implantable Device Sales by Type (2026-2031)
4.1.3 Global Vagus Nerve Stimulation Implantable Device Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Vagus Nerve Stimulation Implantable Device Revenue by Type (2020-2031)
4.2.1 Global Vagus Nerve Stimulation Implantable Device Revenue by Type (2020-2025)
4.2.2 Global Vagus Nerve Stimulation Implantable Device Revenue by Type (2026-2031)
4.2.3 Global Vagus Nerve Stimulation Implantable Device Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Vagus Nerve Stimulation Implantable Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vagus Nerve Stimulation Implantable Device Sales by Application (2020-2031)
5.1.1 Global Vagus Nerve Stimulation Implantable Device Sales by Application (2020-2025)
5.1.2 Global Vagus Nerve Stimulation Implantable Device Sales by Application (2026-2031)
5.1.3 Global Vagus Nerve Stimulation Implantable Device Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Vagus Nerve Stimulation Implantable Device Revenue by Application (2020-2031)
5.2.1 Global Vagus Nerve Stimulation Implantable Device Revenue by Application (2020-2025)
5.2.2 Global Vagus Nerve Stimulation Implantable Device Revenue by Application (2026-2031)
5.2.3 Global Vagus Nerve Stimulation Implantable Device Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Vagus Nerve Stimulation Implantable Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 LivaNova
6.1.1 LivaNova Company Information
6.1.2 LivaNova Description and Business Overview
6.1.3 LivaNova Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 LivaNova Vagus Nerve Stimulation Implantable Device Product Portfolio
6.1.5 LivaNova Recent Developments/Updates
6.2 ReShape Lifesciences
6.2.1 ReShape Lifesciences Company Information
6.2.2 ReShape Lifesciences Description and Business Overview
6.2.3 ReShape Lifesciences Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ReShape Lifesciences Vagus Nerve Stimulation Implantable Device Product Portfolio
6.2.5 ReShape Lifesciences Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Company Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boston Scientific Vagus Nerve Stimulation Implantable Device Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Cyberonics
6.4.1 Cyberonics Company Information
6.4.2 Cyberonics Description and Business Overview
6.4.3 Cyberonics Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cyberonics Vagus Nerve Stimulation Implantable Device Product Portfolio
6.4.5 Cyberonics Recent Developments/Updates
6.5 SenTiva
6.5.1 SenTiva Company Information
6.5.2 SenTiva Description and Business Overview
6.5.3 SenTiva Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SenTiva Vagus Nerve Stimulation Implantable Device Product Portfolio
6.5.5 SenTiva Recent Developments/Updates
6.6 Inspire Medical
6.6.1 Inspire Medical Company Information
6.6.2 Inspire Medical Description and Business Overview
6.6.3 Inspire Medical Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Inspire Medical Vagus Nerve Stimulation Implantable Device Product Portfolio
6.6.5 Inspire Medical Recent Developments/Updates
6.7 NeuroPace
6.7.1 NeuroPace Company Information
6.7.2 NeuroPace Description and Business Overview
6.7.3 NeuroPace Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NeuroPace Vagus Nerve Stimulation Implantable Device Product Portfolio
6.7.5 NeuroPace Recent Developments/Updates
6.8 Stimwave
6.8.1 Stimwave Company Information
6.8.2 Stimwave Description and Business Overview
6.8.3 Stimwave Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Stimwave Vagus Nerve Stimulation Implantable Device Product Portfolio
6.8.5 Stimwave Recent Developments/Updates
6.9 Cerbomed GmbH
6.9.1 Cerbomed GmbH Company Information
6.9.2 Cerbomed GmbH Description and Business Overview
6.9.3 Cerbomed GmbH Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cerbomed GmbH Vagus Nerve Stimulation Implantable Device Product Portfolio
6.9.5 Cerbomed GmbH Recent Developments/Updates
6.10 ImThera Medical
6.10.1 ImThera Medical Company Information
6.10.2 ImThera Medical Description and Business Overview
6.10.3 ImThera Medical Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ImThera Medical Vagus Nerve Stimulation Implantable Device Product Portfolio
6.10.5 ImThera Medical Recent Developments/Updates
6.11 EnteroMedics
6.11.1 EnteroMedics Company Information
6.11.2 EnteroMedics Description and Business Overview
6.11.3 EnteroMedics Vagus Nerve Stimulation Implantable Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 EnteroMedics Vagus Nerve Stimulation Implantable Device Product Portfolio
6.11.5 EnteroMedics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vagus Nerve Stimulation Implantable Device Industry Chain Analysis
7.2 Vagus Nerve Stimulation Implantable Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vagus Nerve Stimulation Implantable Device Production Mode & Process Analysis
7.4 Vagus Nerve Stimulation Implantable Device Sales and 麻豆原创ing
7.4.1 Vagus Nerve Stimulation Implantable Device Sales Channels
7.4.2 Vagus Nerve Stimulation Implantable Device Distributors
7.5 Vagus Nerve Stimulation Implantable Device Customer Analysis
8 Vagus Nerve Stimulation Implantable Device 麻豆原创 Dynamics
8.1 Vagus Nerve Stimulation Implantable Device Industry Trends
8.2 Vagus Nerve Stimulation Implantable Device 麻豆原创 Drivers
8.3 Vagus Nerve Stimulation Implantable Device 麻豆原创 Challenges
8.4 Vagus Nerve Stimulation Implantable Device 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

LivaNova
ReShape Lifesciences
Boston Scientific
Cyberonics
SenTiva
Inspire Medical
NeuroPace
Stimwave
Cerbomed GmbH
ImThera Medical
EnteroMedics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.